← Human Trials & Peer-Reviewed Studies
Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial.
Plain-language guide to PMID 30541089 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 180 participants.
Key Facts
- PMID
- 30541089
- Journal
- The American journal of clinical nutrition
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Dai Q et al. (15 authors)
- DOI
- 10.1093/ajcn/nqy274
- Registered trial
- NCT03265483
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
The aim of this study was to test the hypothesis that magnesium supplementation differentially affects vitamin D metabolism dependent on baseline 25-hydroxyvitamin D [25(OH)D] concentration.
Why It Was Studied
Previous in vitro and in vivo studies indicate that enzymes that synthesize and metabolize vitamin D are magnesium dependent.
Who Took Part
The study group was 180 participants.
PubMed indexes the participants as middle-aged adults and older adults, both men and women.
Subjects were randomly assigned to treatments using a permuted-block randomization algorithm.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
The PPCCT is a double-blind 2 × 2 factorial randomized controlled trial conducted in the Vanderbilt University Medical Center.
Changes in plasma 25-hydroxyvitamin D3 [25(OH)D3], 25-hydroxyvitamin D2 [25(OH)D2], 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] were measured by liquid chromatography-mass spectrometry.
What Was Measured
PubMed files the paper under topics including 24,25-Dihydroxyvitamin D 3, 25-Hydroxyvitamin D 2, Calcifediol, Calcitriol, Dietary Supplements, Ergocalciferols and Kidney.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 180 participants.
Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2018 (The American journal of clinical nutrition), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.